OC
Octagon Capital Advisors LP disclosed a 5.7% stake in DTIL
Octagon Capital Advisors LP reported owning 5.7% of Precision Biosciences Inc (DTIL) (1,651,497 shares) in a Schedule 13G filed Nov 3, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 3, 2026
- Source
- Schedule 13G